Orthofix Medical had a negative return on equity of 21.25% and a negative net margin of 15.18%. The firm had revenue of $196.61 million for the quarter, compared to the consensus estimate of $196. ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February ...

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...